Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Complexes of Oligoribonucleotides with d-Mannitol Modulate the Innate Immune Response to Influenza A Virus H1N1 (A/FM/1/47) In Vivo.

Melnichuk N, Kashuba V, Rybalko S, Tkachuk Z.

Pharmaceuticals (Basel). 2018 Jul 22;11(3). pii: E73. doi: 10.3390/ph11030073.

2.

The MRPS18-2 protein levels correlate with prostate tumor progression and it induces CXCR4-dependent migration of cancer cells.

Mushtaq M, Jensen L, Davidsson S, Grygoruk OV, Andrén O, Kashuba V, Kashuba E.

Sci Rep. 2018 Feb 2;8(1):2268. doi: 10.1038/s41598-018-20765-8.

3.

Ancient permafrost staphylococci carry antibiotic resistance genes.

Kashuba E, Dmitriev AA, Kamal SM, Melefors O, Griva G, Römling U, Ernberg I, Kashuba V, Brouchkov A.

Microb Ecol Health Dis. 2017 Jan 1;28(1):1345574. doi: 10.1080/16512235.2017.1345574. eCollection 2017.

4.

RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo.

Alkasalias T, Alexeyenko A, Hennig K, Danielsson F, Lebbink RJ, Fielden M, Turunen SP, Lehti K, Kashuba V, Madapura HS, Bozoky B, Lundberg E, Balland M, Guvén H, Klein G, Gad AK, Pavlova T.

Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):E1413-E1421. doi: 10.1073/pnas.1621161114. Epub 2017 Feb 7.

5.

S18 family of mitochondrial ribosomal proteins: evolutionary history and Gly132 polymorphism in colon carcinoma.

Mushtaq M, Ali RH, Kashuba V, Klein G, Kashuba E.

Oncotarget. 2016 Aug 23;7(34):55649-55662. doi: 10.18632/oncotarget.10957.

6.

Prostate cancer cells specifically reorganize epithelial cell-fibroblast communication through proteoglycan and junction pathways.

Suhovskih AV, Kashuba VI, Klein G, Grigorieva EV.

Cell Adh Migr. 2017 Jan 2;11(1):39-53. doi: 10.1080/19336918.2016.1182292. Epub 2016 Apr 25.

7.

Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis.

Dmitriev AA, Rosenberg EE, Krasnov GS, Gerashchenko GV, Gordiyuk VV, Pavlova TV, Kudryavtseva AV, Beniaminov AD, Belova AA, Bondarenko YN, Danilets RO, Glukhov AI, Kondratov AG, Alexeyenko A, Alekseev BY, Klein G, Senchenko VN, Kashuba VI.

Dis Markers. 2015;2015:241301. doi: 10.1155/2015/241301. Epub 2015 Sep 28.

8.

Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma.

Nawaz I, Hu LF, Du ZM, Moumad K, Ignatyev I, Pavlova TV, Kashuba V, Almgren M, Zabarovsky ER, Ernberg I.

Oncotarget. 2015 Oct 13;6(31):31493-507. doi: 10.18632/oncotarget.5154.

9.

Tissue-specificity of heparan sulfate biosynthetic machinery in cancer.

Suhovskih AV, Domanitskaya NV, Tsidulko AY, Prudnikova TY, Kashuba VI, Grigorieva EV.

Cell Adh Migr. 2015;9(6):452-9. doi: 10.1080/19336918.2015.1049801.

10.

Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth.

Alexeyenko A, Alkasalias T, Pavlova T, Szekely L, Kashuba V, Rundqvist H, Wiklund P, Egevad L, Csermely P, Korcsmaros T, Guven H, Klein G.

J Exp Clin Cancer Res. 2015 Jun 18;34:62. doi: 10.1186/s13046-015-0178-x.

11.

Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.

Loginov VI, Dmitriev AA, Senchenko VN, Pronina IV, Khodyrev DS, Kudryavtseva AV, Krasnov GS, Gerashchenko GV, Chashchina LI, Kazubskaya TP, Kondratieva TT, Lerman MI, Angeloni D, Braga EA, Kashuba VI.

PLoS One. 2015 May 11;10(5):e0123369. doi: 10.1371/journal.pone.0123369. eCollection 2015.

12.

Proteoglycans as potential microenvironmental biomarkers for colon cancer.

Suhovskih AV, Aidagulova SV, Kashuba VI, Grigorieva EV.

Cell Tissue Res. 2015 Sep;361(3):833-44. doi: 10.1007/s00441-015-2141-8. Epub 2015 Feb 26.

PMID:
25715761
13.

Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent.

Alkasalias T, Flaberg E, Kashuba V, Alexeyenko A, Pavlova T, Savchenko A, Szekely L, Klein G, Guven H.

Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17188-93. doi: 10.1073/pnas.1419554111. Epub 2014 Nov 17.

14.

Epigenetic alterations of chromosome 3 revealed by NotI-microarrays in clear cell renal cell carcinoma.

Dmitriev AA, Rudenko EE, Kudryavtseva AV, Krasnov GS, Gordiyuk VV, Melnikova NV, Stakhovsky EO, Kononenko OA, Pavlova LS, Kondratieva TT, Alekseev BY, Braga EA, Senchenko VN, Kashuba VI.

Biomed Res Int. 2014;2014:735292. doi: 10.1155/2014/735292. Epub 2014 May 22.

15.

Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.

Prudnikova TY, Soulitzis N, Kutsenko OS, Mostovich LA, Haraldson K, Ernberg I, Kashuba VI, Spandidos DA, Zabarovsky ER, Grigorieva EV.

Cancer Med. 2013 Oct;2(5):654-61. doi: 10.1002/cam4.108. Epub 2013 Aug 5.

16.

D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells.

Rosenberg EE, Prudnikova TY, Zabarovsky ER, Kashuba VI, Grigorieva EV.

Tumour Biol. 2014 Apr;35(4):3237-45. doi: 10.1007/s13277-013-1423-6. Epub 2013 Nov 22.

PMID:
24264315
17.

Draft Genome Sequence of Bacillus cereus Strain F, Isolated from Ancient Permafrost.

Brenner EV, Brouchkov AV, Kurilshikov AM, Griva GI, Kashuba E, Kashuba VI, Melefors O, Repin VE, Melnikov VP, Vlassov VV.

Genome Announc. 2013 Aug 1;1(4). pii: e00561-13. doi: 10.1128/genomeA.00561-13.

18.

Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platform.

Midtvedt T, Zabarovsky E, Norin E, Bark J, Gizatullin R, Kashuba V, Ljungqvist O, Zabarovska V, Möllby R, Ernberg I.

PLoS One. 2013 Jun 20;8(6):e66074. doi: 10.1371/journal.pone.0066074. Print 2013.

19.

Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

Senchenko VN, Kisseljova NP, Ivanova TA, Dmitriev AA, Krasnov GS, Kudryavtseva AV, Panasenko GV, Tsitrin EB, Lerman MI, Kisseljov FL, Kashuba VI, Zabarovsky ER.

Epigenetics. 2013 Apr;8(4):409-20. doi: 10.4161/epi.24233. Epub 2013 Mar 11.

20.

NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.

Kashuba V, Dmitriev AA, Krasnov GS, Pavlova T, Ignatjev I, Gordiyuk VV, Gerashchenko AV, Braga EA, Yenamandra SP, Lerman M, Senchenko VN, Zabarovsky E.

Int J Mol Sci. 2012 Oct 18;13(10):13352-77. doi: 10.3390/ijms131013352.

Supplemental Content

Loading ...
Support Center